AOD-9604 Research
Home › Blog › AOD-9604 Guide
Fat LossMetabolism⏱ 11 min read

AOD-9604: The Optimized Lipolytic Fragment for Obesity Research

AOD-9604 is a synthetic 16-amino acid peptide derived from the C-terminal end of Human Growth Hormone. Research distinguishes it as an "optimized" version of HGH Fragment 176-191, specifically designed to maximize fat breakdown without affecting insulin or blood sugar levels.

By Nūmira Research TeamUpdated: May 2026
Buy AOD-9604 →

What is AOD-9604?

AOD-9604 stands for "Advanced Obesity Drug." It was developed in Australia as a more stable and orally bioavailable version of the HGH 176-191 fragment. While full growth hormone has many effects (muscle growth, bone density, etc.), AOD-9604 was engineered to isolate *only* the fat-burning signal.

In extensive Phase 2 human clinical trials, AOD-9604 was studied for its ability to reduce body fat in obese subjects, proving to be one of the most well-tolerated metabolic peptides in scientific literature.

⚗️ Key Research Facts

  • Sequence: Tyr-HGH 176-191 (Stabilized)
  • Primary Goal: Adipose Tissue Reduction
  • Secondary Effect: Cartilage & Joint Repair
  • Bioavailability: High (SubQ & Oral)

Mechanism: Bypassing the GH Receptor

The brilliance of AOD-9604 research lies in its selectivity. It does not bind to the standard Growth Hormone Receptor (GHR). Instead, it appears to interact with **beta-3 adrenergic receptors** found directly on fat cells.

  • Stimulating Lipolysis: Encourages fat cells to release stored triglycerides into the bloodstream.
  • Inhibiting Lipogenesis: Actively prevents the conversion of non-fatty foods into body fat.

Insulin & Blood Sugar Safety

Full-length HGH often causes "insulin resistance" because it competes with insulin in the blood. AOD-9604 avoids this entirely. Research has shown that AOD-9604 does not increase blood glucose levels or stimulate the production of IGF-1, making it a safer alternative for subjects with metabolic sensitivities.

Clinical Research & Weight Loss

Clinical data from Phase 2b trials indicated that subjects taking AOD-9604 experienced a significant reduction in body fat, particularly in the midsection. While it did not meet the rigorous FDA requirements for a "prescription weight loss drug" due to variable results among individuals, it remains a primary tool for researchers studying stubborn fat oxidation.

Joint Health

Unexpected research findings suggest AOD-9604 may help repair damaged cartilage, making it a subject for osteoarthritis studies.

No Bone Growth

Because it doesn't raise IGF-1, it avoids the risk of organ or bone enlargement associated with full HGH.

Research Protocols & Dosing

💡 Research Note: Like its parent fragment, AOD-9604 is most effective in a fasted state when insulin levels are low.
  • Administration: Subcutaneous injection.
  • Research Dose: 300 mcg to 600 mcg per day.
  • Cycle Duration: Research models often observe cumulative benefits over 12–16 week protocols.
  • Side Effects: Extremely rare; primary observations include mild site irritation or headache.
  • Storage: Lyophilized powder in the freezer. Reconstituted solution is stable for up to 30 days in the refrigerator.

Frequently Asked Questions

Is it better than HGH Frag 176-191?

In research, AOD-9604 is considered more stable and has a slightly better absorption profile. However, both compounds share the same core mechanism of action for fat loss.

Can I take it orally?

Research suggests AOD-9604 has a higher oral bioavailability than most peptides, but subcutaneous injection remains the "gold standard" for ensuring 100% systemic absorption in laboratory studies.

Where to buy AOD-9604 in Canada?

Nūmira Peptides offers high-purity AOD-9604 for obesity and metabolic research. Shop AOD-9604 →

AOD-9604 Canada

AOD-9604 — Research Grade

Purity >98% · Stabilized HGH Fragment · Third-party tested

Shop AOD-9604 →